Testosterone Injectable Market size is estimated to reach USD 5 billion by the end of 2035, growing at a CAGR of 4% between 2023 – 2035. In the year 2022, the industry size of testosterone injectable was USD 2 billion. The testosterone injectable is one of the most commonly found and popular types of hormone injection therapy all across the world. Owing to increased awareness about the advantages and efficiency of testosterone replacement therapy, the market is anticipated to gain more approval and recognition among patients and consumers.
The high healthcare expenditure with improved healthcare infrastructure is one of the major factors estimated to drive testosterone injectable market expansion during the forecast period. As per the Centers for Medicare & Medicaid Services (CMS), healthcare spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion. As a share of the nation’s Gross Domestic Product (GDP), health spending accounted for about 19.7%.
|
Base Year |
2022 |
|
Forecast Year |
2023 – 2035 |
|
CAGR |
~4% |
|
Base Year Market Size (2022) |
~USD 2 billion |
|
Forecast Year Market Size (2035) |
~USD 5 billion |
|
Regional Synopsis |
|
Growth Drivers
Challenges
End Users (Hospitals, Homecare, Specialty Clinics)
The hospital segment in the testosterone injectable market is assumed to witness the largest revenue share of 45 % by the end of 2035. Hospitals play a vital role in the distribution and administration of testosterone injectables among people. Most endocrinologists, urologists, and general practitioners from hospitals prescribe testosterone injections to patients. Besides, hospitals also do have a proper environment for the administration of testosterone injectables. In addition, the hospital bed and supporting equipment have been increasingly used for the treatment of patients. Moreover, factors such as increasing spending on healthcare, insurance coverage, and prescribing practices are growth-driving factors for this segment. Spending on Medicaid increased by 9.2% to $734.0 billion in 2021. Spending on private health insurance increased by 5.8% to $1,211.4 billion in 2021.
Dosage Form (Hypogonadism, Autoimmune Conditions, Genetic Disorders, Sex Organ Surgeries)
Testosterone injectable market from the hypogonadism segment is set to witness the highest gain in the near future. Hypogonadism is one type of testosterone deficiency and it can be treated with the help of testosterone injectables which after entering the body increases the level of testosterone in a male body and brings it to normal range. Also, untreated hypogonadism can lead to health conditions such as heart disease or fatality. Therefore, the increasing prevalence of hypogonadism is estimated to propel the segment expansion in the projected period.
Our in-depth analysis of the global testosterone injectable market includes the following segments:
|
Dosage Form |
|
|
Age Group |
|
|
End User |
|
North American Market Statistics
The testosterone injectable market in North America is estimated to grab the largest share and witness noteworthy growth over the projected period. The factors such as growing disposable income, evolving lifestyle, and large access to developed healthcare services are estimated to boost the growth of the market in the region. Moreover, there has been a presence of advanced testosterone treatment in the countries such as the United States. According to a study, the frequency of testosterone treatment in the US has increased by 1.8 to 4-fold over the past 20 years.
European Market Forecast
Moreover, the testosterone injectable market in Europe is also projected to acquire a notable share during the estimated period. This can be propelled by the presence of various medical centers, and rising government initiatives. Moreover, there is easy access to various treatment facilities in developed countries such as the UK, which is further forecasted to surge the market’s growth in the region.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?